Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristyna Valkova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Praxis|March 31, 2017
Kristyna Valkova, Florence Vallelian
Praxis|March 17, 2017
Kristyna Valkova, Florence Vallelian
Clinical Kidney Journal|June 6, 2022
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-termJulia D Fuhrmann, Kristyna Valkova, Seraina von Moos, et al.
Blood Advances|June 20, 2020
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in miceGiada Ingoglia, Ayla Yalamanoglu, Marc Pfefferlé, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Praxis|March 31, 2017
Kristyna Valkova, Florence Vallelian
Praxis|March 17, 2017
Kristyna Valkova, Florence Vallelian
Clinical Kidney Journal|June 6, 2022
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-termJulia D Fuhrmann, Kristyna Valkova, Seraina von Moos, et al.
Blood Advances|June 20, 2020
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in miceGiada Ingoglia, Ayla Yalamanoglu, Marc Pfefferlé, et al.
Pageof 1